Accessibility Menu
Redcare Pharmacy logo

Redcare Pharmacy(OTC) SHPPF

Market Cap$1.31BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-65%
5 Year-71%
1 Year-56%
1 Month+43%
$64.80
+0.00%
+0.00Today
Redcare Pharmacy last closing stock price
MetricPriceDate
Last closeUSD 64.802026-06-15
Redcare Pharmacy stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+17.16%USD 55.312026-05-19
1 month+43.43%USD 45.182026-03-16
3 month+43.43%USD 45.182026-03-16
Year to date-13.6%USD 75.002025-12-23
1 year-56.28%USD 148.222025-05-13
3 year-35.71%USD 100.802023-06-13
5 year-70.68%USD 221.002021-04-12
Since inception-65.04%USD 185.342021-01-06

Redcare Pharmacy Financials at a Glance

Market Cap

$1.31BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€3.22B

Net Income (TTM)

-€42.07M

EPS (TTM)

-$2.38

P/E Ratio

-26.57

Dividend

$0.00

Beta (Volatility)

0.18 (Low)

Price

$64.80

Volume

100

Open

$64.80

Previous Close

$64.80

Daily Range

$64.80 - $64.80

52-Week Range

$45.18 - $148.22

Estimated Earnings Date

Oct 29, 2026

SHPPF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Redcare Pharmacy

Redcare Pharmacy N.V. operates a comprehensive network of online pharmacies across several European countries, including Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. The company provides a wide range of health and wellness products, including prescription and over-the-counter medications, beauty and personal care items, and dietary supplements.

Products and Services
  • Prescription and over-the-counter medications
  • Beauty and personal care products
  • Dietary supplements and wellness items
Growth Outlook
  • Revenue increased to €852.73 million in Q1 2026
  • Gross profit margin improved to 18.95% in Q1 2026
  • Expansion into new European markets is underway
Financial Highlights
  • Net income of -€10.54 million in Q1 2026
  • Operating income margin at -0.44% in Q1 2026
  • Current ratio of 1.54 indicates strong liquidity
Redcare Pharmacy N.V. has shown significant growth potential, particularly with its recent revenue increase in the first quarter of 2026. The improvement in gross profit margin reflects effective cost management strategies. Despite facing challenges with net income, the company's liquidity position remains strong, as indicated by a current ratio above 1. The ongoing expansion into new markets suggests a proactive approach to capturing additional market share in the competitive online pharmacy sector. Investors may find the company's strategic initiatives and market presence noteworthy as it continues to evolve in the healthcare landscape.
AI Generated • Jul 8, 2026

Industry

Food and Staples Retailing

Sector

Consumer Staples

Employees

2,649

CEO

Olaf Heinrich

Website

www.redcare-pharmacy.com

Headquarters

Sevenum, LI 5975 WD, NL

SHPPF Financials

Key Financial Metrics (TTM)

Gross Margin

20.27%

Operating Margin

-0.32%

Net Income Margin

-1.31%

Return on Equity

-9.00%

Return on Capital

-2.72%

Return on Assets

-3.64%

Earnings Yield

-3.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.31BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

20.18M

Volume

100

Avg. Volume

1.603

Financials (TTM)

Gross Profit

€652.59M

Operating Income

-€10.22M

EBITDA

€66.94M

Operating Cash Flow

-€11.37M

Capital Expenditure

-€86.21M

Free Cash Flow

-€97.58M

Cash & ST Invst.

€118.90M

Total Debt

€1.30M

Redcare Pharmacy Performance Analysis

Redcare Pharmacy annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 1,265,743,0201.0%
20232023-12-31EUR 1,944,665,34053.6%
20242024-12-31EUR 2,564,229,06531.9%
20252025-12-31EUR 3,319,034,89529.4%
Redcare Pharmacy sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301.4%
Q42025-12-3110.5%
Q12026-03-317.3%
Q22026-06-300.1%
Redcare Pharmacy annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR -4.54-7.5%
20232023-12-31EUR -0.68-85.1%
20242024-12-31EUR -2.45262.4%
20252025-12-31EUR -2.12-13.7%
Redcare Pharmacy sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-176.6%
Q42025-12-31-300.0%
Q12026-03-3163.9%
Q22026-06-30100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€853.50M

+20.3%

Gross Profit

€188.60M

+11.8%

Gross Margin

22.10%

N/A

Market Cap

$1.31BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$715.72K

N/A

Employees

1,827

N/A

Net Income

€4.70M

-49.8%

EBITDA

€29.30M

-8.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€118.90M

-62.3%

Total Debt

€1.30M

+22.2%

Accounts Receivable

€152.80M

+28.2%

Inventory

€213.30M

+31.8%

Long Term Debt

€0.00

-100.0%

Short Term Debt

€1.30M

+22.2%

Return on Assets

-3.64%

N/A

Return on Invested Capital

-1.26%

N/A

Free Cash Flow

-€11.60M

-212.4%

Operating Cash Flow

€10.80M

-67.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PHMMFPharma Mar, S.A.
$86.09+0.00%
DRWKFDrägerwerk AG & Co. KGaA
$100.47+0.00%
RTEZRest Ez Inc.
$70.00+0.00%
ZRSEFDocMorris AG
$10.24+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About SHPPF

What is the current price of Redcare Pharmacy?

Redcare Pharmacy is trading at $64.80 per share.

What is the 52-week range for Redcare Pharmacy?

Over the past 52 weeks, Redcare Pharmacy has traded between $45.18 and $148.22.

How much debt does Redcare Pharmacy have?

As of the most recent reporting period, Redcare Pharmacy reported total debt of €405.53M.

How much cash does Redcare Pharmacy have on hand?

Redcare Pharmacy reported €87.23M in cash and cash equivalents in its most recent financial results.

What is Redcare Pharmacy’s dividend yield?

Redcare Pharmacy does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services